PMGC HOLDINGS INC. Revenue from Contract with Customer, Including Assessed Tax
PMGC HOLDINGS INC. (ELAB) reported Revenue from Contract with Customer, Including Assessed Tax of $1.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-14
- PMGC HOLDINGS INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $1.31M.
- PMGC HOLDINGS INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $681.99K.
- PMGC HOLDINGS INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $304.14K.
- PMGC HOLDINGS INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $285.95K.
- PMGC HOLDINGS INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $590.08K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.31M 10-Q · filed 2026-08-14 | $1.99M 10-Q · filed 2026-08-14 | $2.29M derived: sum of 3 quarters · filed 2026-08-14 | $2.58M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $681.99K 10-Q · filed 2026-05-15 | $986.13K derived: sum of 2 quarters · filed 2026-05-15 | $1.27M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $304.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $590.08K derived: sum of 2 quarters · filed 2026-03-30 | $590.08K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $285.95K 10-Q · filed 2025-11-14 | $285.95K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |